Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , Aug.
7, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell–based protein expression system, today announced that it will release its financial results for the quarter ended June 30, 2024 and provide a business and clinical update on August 14, 2024. Management will host a conference call with investors to discuss the financial results and provide an update on recent corporate and regulatory developments.
Conference Call Details: Date: Wednesday, August 14, 2024 Time: 8:30 a.m. Eastern Daylight Time (EDT) Toll Free: 1-877-423-9813 International: 1-201-689-8573 Israeli Toll Free: 1-809-406-247 Conference ID: 13747744 Call meTM: https://tinyurl.
com/2n9fhumh The Call meTM feature allows you to avoid the wait for an operator; you enter your phone number on the platform and the system calls you right away. Webcast Details: Company Link: https://ir.protalix.
com/news-events/events Webcast Link: https://tinyurl.com/yb6bu7vs Conference ID: 13747744 Participants are requested to access the call at least 15 minutes ahead of the conference to register, download and install any necessary audio software. A replay of the call will be available for two weeks on the Events Calendar of the Investors section of the Comp.